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Point-of-care glucometry is used commonly in clinical and research settings; however, accuracy 34 
and precision of this method are concerns. The objectives of this study were to determine the accuracy 35 
of glucometry in adult horses and the precision of duplicate measurements. Blood samples were 36 
collected from 62 horses into one plain syringe, one ethylenediaminetetraacetic acid (EDTA) tube and 37 
three fluoride oxalate (FO) tubes. Immediately after collection, glucose concentrations in whole blood 38 
were determined, in duplicate, by glucometry from the syringe (plain whole blood [WB] group), EDTA 39 
tube (EDTA group) and one FO tube (FO group). One FO sample was used to measure plasma glucose 40 
concentration by a laboratory chemistry analyser (LAB group) ≤1 h after collection. The third FO tube 41 
was used to measure plasma glucose concentration by glucometry after 3 h storage (FO3hr group).  42 
 43 
Adequate precision was present for all groups (coefficient of variation: 0.7-3.5%) except WB 44 
(5.5-9.4%). Between groups, correlations were significant (P <0.05) (except WB-EDTA), varied with 45 
group comparison and tended to be lowest for comparisons involving WB.  Mean bias was lowest for 46 
WB-LAB and greatest for FO-LAB and FO3hr-LAB; however, the limits of agreement were ≥4.65 mmol/L 47 
for WB-LAB and ≤2.75 mmol/L for most other comparisons. For the glucometer used, performance is 48 
influenced by sample type: WB is unsuitable, while FO or EDTA samples result in adequate precision 49 
and accuracy, provided under-estimation of glucose concentrations is accounted for by using method-50 
specific reference ranges. Glucometer performance and optimal sample type(s) should be determined 51 
prior to use in horses. 52 
 53 














Regulation of blood glucose concentrations is important in critically-ill horses, as derangements 66 
in glucose concentrations are associated with increased mortality (Hassel et al., 2009; Hollis et al., 67 
2007; Hollis et al., 2008a). Hyperglycaemia is a negative prognostic indicator in critically-ill human 68 
patients, supporting regulation of blood glucose concentration through monitoring and intervention 69 
(Bochicchio et al., 2005; Sung et al., 2005; Vogelzang et al., 2006). Point-of-care glucometry has 70 
become standard in human and equine intensive care settings and testing of insulin dysregulation, 71 
given the ease of measurement, small blood volumes required, and ability for immediate decision-72 
making (Hoedemaekers et al., 2008; Hollis et al., 2008b; Russell et al., 2007; Tack et al., 2012). 73 
However, for optimal patient management, the precision and accuracy of individual glucometers needs 74 
to be determined. Despite extensive use of glucometry in intensive care units and diabetes control in 75 
human medicine, conflicting results of glucometer performance have been reported. In some studies, 76 
glucometry was an accurate alternative to laboratory methods (Ray et al., 2001; Tack et al., 2012). 77 
However, considerable glucometer inaccuracy was reported in other studies (Denfeld et al., 2011; 78 
Hoedemaekers et al., 2008; Kanji et al., 2005), with implications for incorrect decision-making when 79 
tight glycaemic control is necessary. Possible explanations for the disparity in glucometer performance 80 
include haematocrit interference, sample type (whole blood/plasma, capillary/venous/arterial blood) and 81 
analyser type (Gerber and Freeman, 2016; Kanji et al., 2005; Tang et al., 2000).  82 
 83 
There are few published studies of the accuracy and precision of glucometers in horses 84 
(Hackett and McCue, 2010; Hollis et al., 2008b; Hug et al., 2013; Russell et al., 2007) and only one 85 
veterinary-specific glucometer has been validated for horses (Hackett and McCue, 2010). The 86 
influences of sample type, glucose concentration and delays in analysis on results in horses are largely 87 
unknown. In one equine study, glucometry with plasma had excellent agreement with a laboratory 88 
method, while measurements from whole blood did not (Hollis et al., 2008b). In some human and equine 89 
studies, glucometer performance was less reliable when marked hypoglycaemia or hyperglycaemia 90 
was present (Hollis et al., 2008b; Kanji et al., 2005; Khan et al., 2006). Bias in glucometer results may 91 
be important in critically-ill horses where performance at the extremes of blood glucose concentrations 92 
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may influence decision-making and accurate glycaemic control. The objectives of this study were to 93 
determine (1) the accuracy of glucometry in adult horses using blood and plasma samples in 94 
comparison to a laboratory standard method and (2) the precision of duplicate measurements. 95 
 96 
Materials and methods 97 
The study was granted approval by the Animal Care and Ethics Committee, Charles Sturt 98 
University (Approval number 11/043; Approval date September 2011). 99 
Sample collection 100 
Blood samples were obtained from horses that were >1 year of age and from the research herd 101 
of Charles Sturt University (CSU) or presented to the Veterinary Clinical Centre, CSU, for clinical 102 
assessment.  103 
 104 
For each horse, whole blood (WB) was collected from the jugular vein into a 3 mL syringe, one 105 
blood collection tube containing ethylenediaminetetraacetic acid (EDTA) (Vacutainer, Becton 106 
Dickinson) and 3 blood collection tubes containing fluoride oxalate (FO) (Vacutainer, Becton Dickinson). 107 
The tubes were filled to the manufacturer’s designated level. Immediately after collection, the glucose 108 
concentration of WB in the syringe was determined using a human-specific POC glucometer (Accutrend 109 
Plus, Roche Diagnostics), according to the manufacturer’s instructions (WB group). Within 5 min of 110 
blood collection, the blood glucose concentrations in the EDTA tube (EDTA group) and one of the FO 111 
tubes (FO group) was determined using the glucometer. The second FO sample was used for 112 
determination of plasma glucose concentration using the glucometer after storage of the sample for 3 113 
h at 22 oC and separation of the plasma by centrifugation (10 min at 3000 rpm) immediately prior to 114 
analysis (FO3hr group). The third FO tube was used to measure plasma glucose concentration by a 115 
wet chemistry analyser using the hexokinase/glucocose-6-phoshate dehydrogenase method (Konelab 116 
30i, Thermo Fisher Scientific) as the reference method, within 1 h of blood collection and after 117 
centrifugation (10 min at 3000 rpm) (LAB group). For every sample, two glucose concentration 118 
measurements were obtained using the same device. For the WB, EDTA, FO and FO3hr groups, the 119 
same lot number for the glucometer measurement strips and a single glucometer was used throughout 120 




Using the LAB results, samples were categorised as euglycaemic (4.0-7.0 mmol/L) or hyperglycaemic 123 
(>7.0 mmol/L). Raw glucose concentration data for all 62 horses are provided in Appendix A: 124 
Supplementary material. 125 
 126 
Data analysis 127 
Within groups, precision of glucose measurement was determined by calculation of the 128 
repeatability coefficient (RC: 1.96 times the SD of the differences of paired measurements) (Bland and 129 
Altman, 1986). The RC is expected to contain 95% of the differences, and values of <0.8 mmol/L and 130 
<2.0 mmol/L were considered acceptable for euglycaemic and hyperglycaemic samples, respectively, 131 
based on criteria for glucometer performance in humans (Tonyushkina and Nichols, 2009). Within each 132 
group, the coefficient of variation (CV) for repeated glucose measurements was determined: a median 133 
CV of <4% was considered adequate measurement precision (Carr et al., 1995; Chen et al., 2003). 134 
Blood glucose measurements within each group were compared also using Spearman’s correlation as 135 
data were non-normally distributed (Shapiro-Wilk test). Spearman’s correlation coefficients (rs) were 136 
interpreted using the criteria of 0.90-1.00: very high, 0.70-0.89: high, 0.50-0.69: moderate, 0.30-0.49: 137 
low and <0.30: little/no correlation (Domori et al., 2014). 138 
 139 
Between groups, association of paired glucose measurements (first measurement for each 140 
sample) was determined using Spearman’s correlation, and agreement was determined using Lin’s 141 
concordance correlation (Lin, 1989) and the mean bias and 95% limits of agreement (LOA) (Bland and 142 
Altman, 1986). Concordance correlation coefficients (ρc) were interpreted using the criteria of >0.99: 143 
almost perfect, 0.95-0.99: substantial, 0.90-0.95: moderate, <0.90: poor concordance (Domori et al., 144 
2014). Based on criteria for glucometer accuracy for humans (Tonyushkina and Nichols, 2009), 145 
adequate agreement was considered with LOA ≤1.7 mmol/L and ≤2.8 mmol/L for euglycaemic and 146 
hyperglycaemic samples, respectively. The relative difference between paired glucose measurements 147 
for each glucometer group and the LAB group was calculated (POC group-LAB/LAB x 100%) and the 148 
percentage of glucometer results that were within 5%, 10%, 15% or 20% of the LAB glucose 149 
concentration were calculated according to guidelines to describe glucometer performance (Krouwer 150 




All statistical analyses were performed using SPSS Statistics version 20 (IBM). Significance was set at 153 
P <0.05. 154 
 155 
Results 156 
Blood samples were obtained from 62 horses (30 Thoroughbreds, 19 Standardbreds, 5 Quarter 157 
horses, 4 ponies, 3 Arabians, 1 Warmblood and 1 Clydesdale) with a median age of 9.5 years (range 158 
1-23). The study population consisted of 33 geldings, 6 entire male horses and 23 mares. Forty-two 159 
animals were research horses, of which 10 underwent combined glucose and insulin testing performed 160 
for the investigation of insulin dysregulation and had hyperglycaemia. Twenty horses were client-owned 161 
animals that had blood collected for clinical assessment. Forty-nine and 13 horses were euglycaemic 162 
and hyperglycaemic, respectively. No horses were hypoglycaemic. 163 
 164 
For euglycaemic and hyperglycaemic samples, RC and CV values indicated adequate 165 
repeatability for all groups with the exception of WB (Table 1). For all glucose concentration categories, 166 
the RC and CV values were smallest and largest for the LAB and WB groups, respectively. For all 167 
glucose measurements, rs was significant and the strength of correlation was moderate to very high 168 
(Table 1).  169 
 170 
Between groups, rs was significant for all comparisons, with the exception of WB-EDTA for 171 
euglycaemic samples (Table 2). Correlation and concordance of glucose measurements varied 172 
substantially with group comparison and glucose concentration (Table 2). For all categories, rs and 173 
concordance tended to be lowest for comparisons between WB and other groups.  The bias and 95% 174 
LOA for agreements between groups are provided in Table 3. Bland-Altman plots are provided in 175 
Appendix A: Supplementary material. 176 
 177 
No group had 95% of the glucose measurements within 5-20% of the LAB results, with the 178 





The results of this study demonstrate that glucometer precision and accuracy can be influenced 182 
by blood sample type and storage. Poor glucometer performance occurred with WB without 183 
anticoagulant, while anticoagulated blood (EDTA, FO) and plasma (FO3hr) resulted in improved 184 
glucometer repeatability and agreement with the laboratory standard, albeit with underestimation of 185 
glucose concentration. In addition, precision and accuracy varied across the glycaemic range, 186 
supporting the recommendation that glucometer performance should be assessed in clinically-relevant 187 
glucose ranges (hypo-, eu- and hyperglycaemia) (Gerber and Freeman, 2016). Determination of 188 
glucometer performance is important for patient care, particularly in intensive care settings. In both 189 
humans and horses, glycaemic abnormalities are associated with a worse prognosis for survival 190 
(Bochicchio et al., 2005; Hassel et al., 2009; Hollis et al., 2008a; Sung et al., 2005) and monitoring and 191 
regulation of blood glucose concentrations is associated with improved outcomes in critically-ill humans 192 
(Lewis et al., 2004; Sung et al., 2005). While glucometry provides rapid results for immediate patient-193 
side decision making, poor accuracy and precision may lead to erroneous clinical assessment and 194 
management (Hoedemaekers et al., 2008; Kanji et al., 2005; Russell et al., 2007).  195 
 196 
For all categories, WB had poor precision (CV: 5.5-9.4%, RC: 2.14-2.94 mmol/L). For 197 
euglycaemic animals, a difference of over 2.14 mmol/L may alter clinical interpretations, suggesting that 198 
WB is inappropriate for this glucometer. The reason for this poor precision is unknown; however, it may 199 
involve the interaction of horse erythrocytes with the test strip. The strips filter erythrocytes while plasma 200 
diffuses to the reagents and sensor for glucose measurement and differences in the sizes of human 201 
and horse erythrocytes and rouleaux formation may be sources of pre-analytic error when WB was 202 
used. Further, glucometers designed for humans assume a stable relationship of glucose 203 
concentrations between erythrocytes and plasma, and differences in glucose distribution between 204 
humans and horses are likely (Coldman and Good, 1967; Hackett and McCue, 2010). In one study 205 
(Hackett and McCue, 2010), a veterinary glucometer coded for equine use (and likely species-specific 206 
assumption of glucose distribution) accurately measured glucose concentrations in WB, while in other 207 
studies, plasma provided superior agreement with a laboratory method than WB when human-specific 208 
glucometers were used in horses (Hollis et al., 2008b) and alpacas (Tennent-Brown et al., 2011). These 209 
findings indicate that the performance of individual glucometers, including influence of sample type, 210 
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should be assessed prior to use in horses, as discrepancies in accuracy and precision may influence 211 
decision-making.   212 
 213 
For both euglycaemic and hyperglycaemic samples, the RC and CV values for the EDTA, FO 214 
and FO3hr groups were consistent with acceptable precision. Glucometer precision in equine practice 215 
has been reported once previously, where the CV of a veterinary glucometer that uses WB was 1.3% 216 
(Hackett and McCue, 2010). Using described values (<3.5-4%) for glucometry in human medicine (Carr 217 
et al., 1995; Chen et al., 2003), the CVs for EDTA, FO and FO3hr in our study indicate that the precision 218 
of the glucometer with these sample types is adequate for horses, while WB resulted in poor precision.  219 
 220 
When all samples were considered, all glucometer groups had moderate or high correlation 221 
with LAB. However, rs increases with a greater range of measured values (Bland and Altman, 1986) 222 
and the strengths of association may have been artificially improved. Importantly, only low to moderate 223 
correlations between groups and LAB were present for euglycaemic samples, emphasising the 224 
importance of determining glucometer performance within clinically-relevant glucose concentration 225 
ranges. Similarly, ρc values were influenced by glucose concentration category, and demonstrated poor 226 
agreement of the glucometer with LAB for euglycaemic samples and often poor agreement between 227 
glucometer groups for euglycaemic and hyperglycaemic samples, suggesting that results should not be 228 
used interchangeably with reference laboratory methods or when different sample types are used. 229 
However, the magnitude of the lack of agreement cannot be determined using this method.  230 
 231 
The mean bias and 95% LOA results revealed variable agreement between glucometer groups 232 
and LAB. Whole blood had the poorest agreement (LOA ≥4.7 mmol/L), representing differences with 233 
risk of clinical misinterpretation. Similarly, when used in human-specific glucometers, WB was 234 
associated with poor agreement with a laboratory method in foals (Russell et al., 2007), adult horses 235 
(Hollis et al., 2008b), alpacas (Tennent-Brown et al., 2011) and dogs (Cohen et al., 2009). In contrast, 236 
good accuracy of veterinary-specific glucometers with WB has been demonstrated for horses (Hackett 237 
and McCue, 2010) and alpacas (Tennent-Brown et al., 2011), which may reflect more accurate 238 
programmed assumptions of glucose distribution between plasma and erythrocytes. The selection of 239 
acceptable LOA is a clinical, rather than a statistical decision, and for the current study, <1.7 mmol/L 240 
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(euglycaemic samples) and <2.8 mmol/L (hyperglycaemic samples) were chosen, based on glucometer 241 
performance criteria for humans (Tonyushkina and Nichols, 2009). Using these LOA values, acceptable 242 
agreement was present for LAB-EDTA, LAB-FO, LAB-FO3hr and FO-FO3hr (euglycaemic samples) 243 
and LAB-FO, LAB-FO3hr and FO-FO3hr (hyperglycaemic samples). The FO and FO3hr groups had 244 
the smallest LOA ranges, which are unlikely to alter clinical interpretation, irrespective of glucose 245 
concentration. While acceptable agreement between the EDTA and LAB groups was present for 246 
euglycaemic samples, proportional bias with increasing glucose concentration was present, suggesting 247 
that EDTA is not suitable for interchangeable use with the laboratory method when hyperglycaemia is 248 
present. Proportional bias has occurred in previous studies of glucometer performance in veterinary 249 
species (Cohen et al., 2009; Tennent-Brown et al., 2011), indicating that assessment of glucometer 250 
accuracy over a wide glucose concentration range is necessary. In the current study, there was constant 251 
bias with underestimation of glucose concentrations by the glucometer for the EDTA, FO and FO3hr 252 
groups. For FO and EDTA, this may, in part, reflect higher glucose concentrations in plasma, which are 253 
approximately 10-15% higher than those in blood (Gerber and Freeman, 2016), emphasising that 254 
results are often not interchangeable. The mean bias for FO-LAB (-1.17 mmol/L) is similar to an 255 
estimated difference of 10-15% between plasma (LAB) and blood (FO). Constant bias with glucometer 256 
use in horses and other species has been demonstrated previously (Beemer et al., 2013; Cohen et al., 257 
2009; Russell et al., 2007; Tennent-Brown et al., 2011), although the direction of the bias varied 258 
between studies. Given the small size of the hyperglycaemic group in the current study, further 259 
investigation of the effects of hyperglycaemia on glucometer performance using larger numbers of 260 
hyperglycaemic and systemically-ill horses is warranted. 261 
 262 
With the exception of FO-FO3hr, there was, at best, only moderate agreement between 263 
glucometer groups, demonstrating that different sample types should not be used for monitoring of 264 
glucose concentrations in an individual animal. The results of the current and previous studies (Hollis 265 
et al., 2008b; Russell et al., 2007) suggest that human-specific glucometers may be inaccurate when 266 
used in horses (due to systematic bias), and careful consideration of appropriate sample type  is 267 
necessary for specific glucometers. The poor agreement between WB and other groups, can be 268 
anticipated from the large RC for WB, as repeatability limits the amount of achievable agreement (Bland 269 




No glucometer group had 95% of the measurements within 5-20% of the LAB results, with the 272 
exception of the EDTA group for hyperglycaemic samples. In human medicine, recommended 273 
glucometer performance criteria include 95-100% of measurements within 5-20% of the laboratory 274 
method for acceptable accuracy (Tonyushkina and Nichols, 2009). While similar standards for 275 
glucometer accuracy in horses have not been established, our results, overall, reflected glucometer 276 
inaccuracy, irrespective of sample type. Similarly, glucometer performance often failed to achieve 277 
adequate accuracy in alpacas (Beemer et al., 2013) and dogs (Cohn et al., 2000). Glucometer 278 
inaccuracy may result in erroneous clinical decisions if glucose reference ranges for a reference 279 
laboratory method are used. However, systematic bias may not preclude individual glucometer use if a 280 
conversion factor is applied. Alternatively, for sample types with acceptable repeatability (e.g. EDTA, 281 
FO, FO3hr), establishing glucometer-specific reference ranges for each sample type would maximise 282 
the application of the glucometer and avoid errors in clinical-decision making.  283 
 284 
The accuracy of glucometry using FO3hr was lower than for the FO group. In blood, glucose 285 
continues to be utilised by erythrocytes at a rate of approximately 5-7% per h (Chan et al., 1989), and 286 
while FO prevents glycolysis through inhibition of enolase, enzymes ‘upstream’ of enolase are 287 
unaffected and continue to metabolise glucose-6-phosphate (Shi et al., 2009). Consequently, glucose 288 
concentrations in FO blood samples decrease over the first h after collection and immediate separation 289 
of serum or plasma is recommended to preserve glucose concentrations (Chan et al., 1989). In humans, 290 
glucose concentrations in FO blood decreased, on average, by 0.39 mmol/L during 4 h transit to the 291 
laboratory (Shi et al., 2009). Glucose utilisation after blood collection may have, in part, reduced the 292 
repeatability and agreement for the FO3hr group in comparison to the FO group.  293 
 294 
A limitation of this study was the lack of hypoglycaemic samples. A hypoglycaemic group would 295 
have allowed determination of glucometer performance across a larger glycaemic range. However, the 296 
tendency of the glucometer to under-estimate glucose concentrations is less likely to result in erroneous 297 
treatment decisions in hypoglycaemic horses. Further, the effect of haematocrit on glucometer accuracy 298 
was not assessed. The haematocrit can influence glucometer accuracy in humans, alpacas and dogs, 299 
with decreased and increased haematocrit levels resulting in a positive and negative bias, respectively 300 
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(Paul et al., 2011; Tang et al., 2000; Tennent-Brown et al., 2011). In a previous equine study (Hollis et 301 
al., 2008b), there was no influence of haematocrit on glucometer accuracy. While haematocrit was not 302 
assessed in our study, an influence of erythrocytes on glucometer performance due to interactions with 303 
the test strip filters cannot be discounted. In addition, other sources of analytic error from interference 304 
(e.g. lipaemia, bilirubin, pH, drugs) (Gerber and Freeman, 2016) were not recorded. To minimise 305 
methodological influences on glucometer performance (Beemer et al., 2013; Hollis et al., 2008b), 306 
measurements were made by a single operator using one glucometer, all test strips had the same lot 307 
number and were used within the expiry date and the glucometer and test strips were used according 308 
to the manufacturer’s instructions, including calibration procedure, storage and operation temperature 309 
and humidity.  310 
 311 
Conclusion 312 
The precision and accuracy of the glucometer was influenced by sample type. Whole blood is 313 
unsuitable for glucometry using this equipment as inaccuracy has potential for erroneous clinical 314 
decisions. Glucometry using blood collected into FO or EDTA tubes results in precision and accuracy 315 
sufficient for clinical use, provided trends in under-estimation of blood glucose concentration are 316 
accounted for by determination of method-specific reference ranges. Given the lack of readily available 317 
validated equine-specific glucometers, these findings emphasise the importance of assessing individual 318 
glucometer performance and optimal sample type prior to use in horses. 319 
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Table 1: Repeatability coefficient (RC), median [interquartile range] coefficient of variation (CV) and 476 
Spearman’s correlation coefficient (rs) for paired measurements of glucose concentration for each group 477 
and for each category of glucose concentration. (EDTA = ethylenediaminetetraacetic acid, FO = fluoride 478 
oxalate, FO3hr = fluoride oxalate and 3 h of storage, LAB = fluoride oxalate and wet chemistry analyser 479 

















WB 2.36 8.1 [3.3-14.6] 0.79 <0.001 
EDTA 0.86 2.9 [1.5-5.3]  0.85 <0.001 
FO 0.61 2.2 [1.6-4.1] 0.92 <0.001 
FO3hr 0.82 3.5 [1.9-6.3] 0.92 <0.001 
LAB 0.34 1.4 [1.1-2.5] 0.95 <0.001 




WB 2.14 9.4 [3.6-16.5] 0.60 <0.001 
EDTA 0.74 3.1 [1.6-5.9] 0.71 <0.001 
FO 0.50 3.3 [1.7-4.1] 0.85 <0.001 
FO3hr 0.78 3.5 [1.9-7.3] 0.62 <0.001 
LAB 0.33 1.5 [1.3-2.8] 0.90 <0.001 




WB 2.94 5.5 [2.5-9.0] 0.83 <0.001 
EDTA 1.24 1.9 [0.9-2.5] 0.93 <0.001 
FO 0.93 2.0 [1.0-3.0] 0.98 <0.001 
FO3hr 0.94 2.1 [1.3-3.9] 0.99 <0.001 
LAB 0.39 0.7 [0.4-1.3] 1.00 <0.001 
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Table 2: Lin’s concordance (ρ) and Spearman’s correlation coefficient (rs) analysis of paired glucose 486 
measurements between groups for each glucose concentration category. (EDTA = 487 
ethylenediaminetetraacetic acid, FO = fluoride oxalate, FO3hr = fluoride oxalate and 3 h of storage, 488 
LAB = fluoride oxalate and wet chemistry analyser at laboratory, WB = whole blood). 489 
Group 
comparison 
Glucose concentration category 
All samples 
(n=62) 
 Euglycaemic samples 
(n=49) 




rs P  ρ 95% 
CI 






























































































































































Table 3: Summary of the Bland Altman analyses of agreement for glucose measurement between 493 
groups for each category of glucose concentration. (EDTA = ethylenediaminetetraacetic acid, FO = 494 
fluoride oxalate, FO3hr = fluoride oxalate and 3 h of storage, LAB = fluoride oxalate and wet chemistry 495 
analyser at laboratory, WB = whole blood). 496 
Group 
comparison 
 Glucose concentration category 




















WB-LAB  0.07 2.44 -2.31  0.11 2.44 -2.21  -0.12 2.53 -2.76 
WB-EDTA  0.44 2.91 -2.04  0.62 3.08 -1.84  -0.26 1.83 -2.35 
WB-FO  1.24 3.79 -1.30  1.18 3.67 -1.31  1.47 4.27 -1.33 
WB-FO3hr  1.04 3.56 -1.48  0.98 3.33 -1.37  1.26 4.40 -1.88 
EDTA-LAB  -0.37 0.94 -1.68  -0.51 0.25 -1.26  0.15 2.38 -2.09 
EDTA-FO  0.80 2.42 -0.81  0.56 1.40 -0.29  1.73 4.16 -0.69 
EDTA-
FO3hr 
 0.60 2.32 -1.11  0.36 1.24 -0.52  1.52 4.25 -1.20 
FO-LAB  -1.17 -0.27 -2.07  -1.07 -0.36 -1.77  -1.58 -0.47 -2.70 
FO-FO3hr  -0.20 0.57 -0.97  -0.20 0.54 -0.93  -0.21 0.70 -1.12 









Table 4: Percentage of glucose measurements determined for each blood glucose category and each 503 
glucometer group that were within 5, 10, 15 or 20% of the glucose measurement determined by the 504 
laboratory reference method. (EDTA = ethylenediaminetetraacetic acid, FO = fluoride oxalate, FO3hr = 505 
fluoride oxalate and 3 h of storage, LAB = fluoride oxalate and wet chemistry analyser at laboratory, 506 










WB All samples (n=62) 24.2 41.9 56.5 67.7 
 Euglycaemic samples (n=49) 20.4 36.7 51.0 61.2 
 Hyperglycaemic samples 
(n=13) 
38.5 61.5 76.9 92.3 
EDTA All samples (n=62) 22.6 56.7 83.3 93.3 
 Euglycaemic samples (n=49) 14.3 51.0 81.6 91.8 
 Hyperglycaemic samples 
(n=13) 
53.8 76.9 84.6 100 
FO All samples (n=62) 1.6 8.3 26.7 56.7 
 Euglycaemic samples (n=49) 2.0 4.1 14.3 44.9 
 Hyperglycaemic samples 
(n=13) 
0.0 23.1 69.2 92.3 
FO3hr All samples (n=62) 8.1 23.3 40.0 70.0 
 Euglycaemic samples (n=49) 6.1 16.3 32.7 65.3 
 Hyperglycaemic samples 
(n=13) 
15.4 53.8 69.2 84.6 
